CoChat

Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives

Gaballa, Sherif A., Kompella, Uday B., Elgarhy, Omar, Alqahtani, Ali M., Pierscionek, Barbara, Alany, Raid G., Abdelkader, Hamdy · 2021 · Drug Delivery and Translational Research

The DOI matches its Crossref record; 338 of the 350 references it cites were found in a registry or an index.

Abstract

Corticosteroids remain the mainstay of the treatment for various ocular conditions affecting the ocular surface, anterior and posterior segments of the eye due to their anti-inflammatory, anti-oedematous, and anti-neovascularization properties. Prednisolone, prednisolone acetate, dexamethasone, triamcinolone acetonide, fluocinolone acetonide, and loteprednol etabonate are amongst the most widely used ophthalmic corticosteroids. Corticosteroids differ in their activity and potency in the eye due to their inherent pharmacological and pharmaceutical differences. Different routes and regimens are available for ocular administration of corticosteroids. Conventional topical application to the eye is the route of choice when targeting diseases affecting the ocular surface and anterior segment, while periocular, intravitreal, and suprachoroidal injections can be potentially effective for posterior segment diseases. Corticosteroid-induced intraocular pressure elevation and cataract formation remain the most significant local risks following topical as well as systemic corticosteroid administration. Invasive drug administration via intracameral, subconjunctival, and intravitreal injection can enhance ocular bioavailability and minimize dose and dosing frequency of administration, yet may exacerbate ocular side effects of corticosteroids. This review provides a critical appraisal of the ophthalmic uses of corticosteroid, routes of administration, drug delivery fundamentals and novel ocu…

Overview

Integrity signals

Registry

Crossref · 10.1007/s13346-020-00843-z

Cites

338 of 338 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 338 references

Research works printed but not linked: 8

  1. Haller JA. Intravitreal corticosteroids: a review of therapeutic and surgical applications. Retina Today. 2009;S1:1–15.
  2. Moffat AC, et al. Clarke’s analysis of drugs and poisons. Vol. 3. London: Pharmaceutical press; 2011.
  3. Alberth M, et al. Lipophilicity, solubility and permeability of loteprednol etabonate: a novel, soft anti-inflammatory steroid. Aust J Biol Sci. 1991;2(2):115–25.
  4. YANG Y, et al. Intravitreal corticosteroids in diabetic macular edema. Retina. 2015;35:2440–9. · DOI
  5. Jones R, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006;17:163–7.
  6. Wilson M. Epidemiology of chronic open-angle glaucoma. Glaucomas. 1996;2:753–68.
  7. Patane MA, et al. Ocular iontophoresis for drug delivery. Retina Today. 2011;6:64–6.
  8. Patane M, et al. Randomized, double-masked study of four iontophoresis dose levels of EGP-437 in non-infectious anterior segment uveitis subjects. Invest Ophthalmol Vis Sci. 2010;51(13):5263.

Cited by

See all 294

Metadata

Authors
Gaballa, S. A., Kompella, U. B., Elgarhy, O., Alqahtani, A. M., Pierscionek, B., Alany, R. G., & Abdelkader, H.
Affiliations
  • Minia University (EG)
  • University of Colorado Anschutz (US)
  • King Khalid University (SA)
  • University of Staffordshire (GB)
  • University of Auckland (NZ)
  • Deraya University (EG)
Corresponding author
Abdelkader, Hamdy
Venue
Drug Delivery and Translational Research
Published
2020-09-08
Volume
11
Issue
3
Pages
866-893
ISSN
  • 2190-393X (ISSN-L)
  • 2190-3948
OpenAlex
W3083822372
Cited by
255
References
350
Citations by year
2026: 36 · 2025: 58 · 2024: 69 · 2023: 52 · 2022: 28 · 2021: 11 · 2020: 1
FWCI
2.02
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Drug Delivery and Translational Research (publishedVersion)
  • PubMed (publishedVersion)
  • Research Repository (Kingston University London) (acceptedVersion)
  • Staffordshire Online Repository (Staffordshire University) (acceptedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
Keywords
ocular drug delivery, prednisolone, dexamethasone, triamcinolone acetonide, fluocinolone acetonide, loteprednol etabonate, intravitreal injection, intracameral injection, suprachoroidal injection, periocular injection, topical ocular administration, intraocular pressure elevation, cataract formation, ocular surface disease, anterior segment diseases, posterior segment diseases, ocular implants, anti-inflammatory therapy, ocular adverse effects
MeSH terms
Adrenal Cortex Hormones, Eye Diseases, Glucocorticoids, Humans, Ophthalmology, Triamcinolone Acetonide, Drug Delivery Systems, Administration, Ophthalmic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. https://app.cochat.ai/papers/10.1007/s13346-020-00843-z
The paper
Gaballa, S. A., Kompella, U. B., Elgarhy, O., Alqahtani, A. M., Pierscionek, B., Alany, R. G., & Abdelkader, H. (2021). Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-020-00843-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.